Participation Studies

This page provides people living with mental illness, their families, and mental health researchers with an opportunity to connect in mental health research studies.

NAMI-NYC Metro does not endorse any study on this page. Information is provided purely as a public service.

A group wishing to post on this page must submit their current IRB approval for the study, in addition to a written synopsis of your study answering the following:

  • A title
  • A brief description of the study.
  • Is the study therapeutic (offering treatment) or non-therapeutic?
  • Is the study funded? If yes, provide source of all funding; e.g., non-profit organization, governmental agency, or for-profit corporation including any ties to the pharmaceutical industry.
  • Who will be conducting the study? E.g. non-profit, government, hospital, or for-profit corporation, including any companies that run clinical trials.
  • Will subjects be paid? Include payment schedule and amount.

Current Studies

September 2017: First Episode Psychosis Research Study

The Schizophrenia Research Program at NYU Langone Health, is currently seeking individuals (ages 16-30) with a diagnosis of schizophrenia, schizotypal, or schizophreniform disorder who have not taken antipsychotic medication for at least 4 weeks to participate in our research study funded by the National Institute of Mental Health.

In our study, we are looking for an alternative treatment for individuals with early psychosis. We are trying to see if a single dose of an anticonvulsant medication may be able to quiet down a specific part of the brain.

The study involves:

  • Two study visits
  • Two brain imaging scans
  • One single dose of Keppra (an FDA approved anticonvulsant medication) or placebo.

If eligibility criteria are met, participants will receive $200 for the completion of the study in addition to reimbursement for travel. If you are interested in participating or want more information please call or text our study team at (917) 565-1581 or email us at GoffLab@nyumc.org.

August 2017: A qualitative study that explores the lived experience of trauma survivors who have experienced misdiagnosis

Announcing a research project exploring the experiences of individuals who report a history of exposure to trauma but in the past did not receive a diagnosis that reflected recognition of their trauma-related reactions.

If you have been exposed to a traumatic event (such as the loss of a loved one or domestic violence), sought help from a mental health practitioner, and were not accurately diagnosed for trauma reactions, please consider participating in this study. You will have the opportunity to share how being wrongly diagnosed impacted you. Taking part in this study may lead to greater understanding of experiences, which could help develop future policies and programs to assist in accurately diagnosing individuals exposed to trauma and inform appropriate services.

I am a social worker and doctoral candidate at Adelphi University working on this research as a requirement for my degree. If you take part in this study, we will arrange to meet at a day and time that is convenient for you. We will also arrange to meet in a public place, such as the Manhattan Center at Adelphi University or a different public location that you are comfortable with. Everything you share will be kept confidential. Participation will include three separate interviews, 60-90 minutes each, for a total of 4-5 hours. At the end of the last interview session, we will take 1-2 hours to review the transcripts.

Participants must be 18 years or older. There will be no compensation for your participation.

If you are interested in participating in this study, or if you have any questions and would like more information, please contact Lisa Henshaw, LCSW at Lhenshaw@adelphi.edu or call (516) 316-6845.

June 2017: Brain Imaging Study of Hearing Voices

We are seeking patients living with schizophrenia (ages 18-55) to participate in an imaging study investigating the mechanisms underlying auditory hallucinations in psychosis.

  • The study involves non-invasive MRI scans, computer tasks, and interviews at the New York State Psychiatric Institute, in New York City.
  • Earn up to $450 (partly depending on task performance) plus travel costs.
  • For more information, call 646-774-8137, or email bakerse@nyspi.columbia.edu.

May 2017: Schizophrenia & Bipolar Research Study

We are looking for young adults 18-30 years old who have been diagnosed with schizophrenia, schizoaffective disorder, or bipolar disorder. You may be eligible to participate in a MRI research study that aims to understand the biology of schizophrenia disorder and bipolar disorder and their relation to cognition. We’re also looking for siblings.

  • Young adults (18-30 years old) with a diagnosis of schizophrenia or schizoaffective disorder.
  • Young adults (18-30 years old) with a diagnosis of bipolar disorder who have also had the experience of hearing or seeing things that other can’t, or having beliefs that others don’t agree with.
  • The sibling of a young adult who has been diagnosed with schizophrenia, schizoaffective disorder, or bipolar disorder and who has also had the experience of hearing or seeing things that other can’t, or having beliefs that others don’t agree with.

The study involves no treatment or modification of current treatment.

You will be compensated for your participation in the study.

If you are interested in participating please contact our coordinator at: cbibrainlab@nyumc.org or 212-263-3945 for more information.

April 2017: Clinical trial of a drug called Rapastinel

Are you currently taking a medication but still feeling depressed?

If you’re 18-65 years old, have been diagnosed with Major Depressive Disorder, and are experiencing the symptoms below, you may be eligible to participate in a clinical research study of an investigational product. All study related drug and visits will be provided to you at no cost.

Hopelessness, sadness, loss of interest, decreased energy, difficulty concentrating.

Our team at Fieve Clinical Research is currently recruiting patients for a randomized, double-blind, phase-III clinical trial of a drug called Rapastinel. The investigational product (IP) is being tested for safety and efficacy as an adjunctive therapy for treatment-resistant depression. The trial includes 12 visits over a six-week period, with a three-week dosing period where the subject will receive either 450 mg of the study drug administered via IV, or will receive a placebo. Participants will remain on their current antidepressant treatment during the trial. Eligible participants must be between the ages of 18-65, not responding to their current FDA-approved antidepressant treatment, and be currently depressed.

Subjects will be compensated $50 per study visit, for a total of $600 if all visits are completed.

Call (212) 772-3570.

April 2017: Clinical Research Study -- Investigational Medicinal Product for Major Depression

If your child is affected by depression and still experiencing its symptoms – you may be interested in the Kites study. Kites is an international clinical research study that is looking at the safety and effectiveness of an investigational medicinal product for major depression in children and adolescents.

The Kites study team is looking for young people who are:

  • aged between 7 and 17
  • diagnosed with major depressive disorder (MDD)
  • being treated for depression as an outpatient
  • available to take part in the study for up to 16 weeks

If your child meets these criteria and you would like to find out more about the Kites study, please go to www.kites-study.com or contact Walid Elsharkawi at walidelsharkawi.mbm@gmail.com or Marie Grant at mariegrant.mbm@gmail.com for more information. They can also be reached via phone at 646-678-4196.

September 2016: The Role of Dysmyelination in Cognitive Impairment of Psychotic Spectrum Disorders

New York University School of Medicine: Brain Imaging Study

We are recruiting 18-30 year old participants who have been diagnosed with schizophrenia or bipolar disorder with psychosis in the last five years. An initial telephone screening and clinical interview will establish eligibility for the study.

The primary objective of this study is to understand how brain anatomy relates to function and health. This study is funded by the National Institute of Mental Health and is conducted at New York University School of Medicine, Department of Radiology.

The study involves:

  • Clinical assessment
  • MR scanning
  • Blood draw
  • Cognitive Assessment

This is a non-therapeutic study that does not involve treatment and does not interfere with any ongoing treatments.

If eligibility criteria are met, a compensation of $160 will be provided for the completion of the study. For more information please contact Mariana Lazar at mariana.lazar@nyumc.org or 212-263-3348.

August 2016: Genomic Psychiatry Cohort Study: Schizophrenia, Bipolar Disorder

We are currently seeking individuals 18 years or older diagnosed with schizophrenia or bipolar disorder to take part in a genetics study at NYU School of Medicine. The study’s purpose is to investigate the genetic risks associated with these chronic mental illnesses.

The study involves a brief screening questionnaire, a diagnostic interview, two short questionnaires asking about your history of trauma and aggression, and a blood draw of no more than 4 tablespoons. The study should take 2-3 hours to complete and you will be compensated $50 in cash.

If you are interested in participating, please contact Mara at Inspiresresearch@gmail.com or by phone at (646) 754-4817 between the hours of 9:30am-5pm MondayFriday.